Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muharrem Muftuoglu

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Cell Signaling|April 4, 2025
Sample multiplexing in CyTOF: Path to optimize single-cell proteomic profilingMuharrem Muftuoglu, Michael Andreeff
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 20, 2020
Ab initio spillover compensation in mass cytometry dataQi Miao, Fang Wang, Jinzhuang Dou, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Scientific Reports|June 12, 2021
Extended live-cell barcoding approach for multiplexed mass cytometryMuharrem Muftuoglu, Li Li, Shaoheng Liang, et al.
JCI Insight|March 1, 2022
In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individualsLi Li, Muharrem Muftuoglu, Shaoheng Liang, et al.
The New England Journal of Medicine|October 11, 2018
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal LeukoencephalopathyMuharrem Muftuoglu, Amanda Olson, David Marin, et al.
Cell Reports. Medicine|May 11, 2024
Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult miceRasoul Pourebrahim, Rafael Heinz Montoya, Hiroki Akiyama, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Frontiers of Medicine|April 15, 2023
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapyZixun Yan, Li Li, Di Fu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53Li Li, Muharrem Muftuoglu, Edward Ayoub, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Cell Signaling|April 4, 2025
Sample multiplexing in CyTOF: Path to optimize single-cell proteomic profilingMuharrem Muftuoglu, Michael Andreeff
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 20, 2020
Ab initio spillover compensation in mass cytometry dataQi Miao, Fang Wang, Jinzhuang Dou, et al.
Frontiers in Immunology|May 26, 2022
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX ModelsHong Mu-Mosley, Lauren Ostermann, Muharrem Muftuoglu, et al.
Scientific Reports|June 12, 2021
Extended live-cell barcoding approach for multiplexed mass cytometryMuharrem Muftuoglu, Li Li, Shaoheng Liang, et al.
JCI Insight|March 1, 2022
In-depth analysis of SARS-CoV-2-specific T cells reveals diverse differentiation hierarchies in vaccinated individualsLi Li, Muharrem Muftuoglu, Shaoheng Liang, et al.
The New England Journal of Medicine|October 11, 2018
Allogeneic BK Virus-Specific T Cells for Progressive Multifocal LeukoencephalopathyMuharrem Muftuoglu, Amanda Olson, David Marin, et al.
Cell Reports. Medicine|May 11, 2024
Age-specific induction of mutant p53 drives clonal hematopoiesis and acute myeloid leukemia in adult miceRasoul Pourebrahim, Rafael Heinz Montoya, Hiroki Akiyama, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Frontiers of Medicine|April 15, 2023
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapyZixun Yan, Li Li, Di Fu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2025
Somatic TP53 Mutations Drive T and NK Cell Dysfunction in AML and Can be Rescued by Reactivating Wild Type p53Li Li, Muharrem Muftuoglu, Edward Ayoub, et al.
Pageof 3